US 10961297
BTLA fusion protein agonists and uses thereof
granted A61KA61K38/00A61K38/17
Quick answer
US patent 10961297 (BTLA fusion protein agonists and uses thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61K38/17, A61K38/177, A61K38/1793